COVID-19 SAFE Enrollment
NCT04506268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 412
Last updated 2021-03-11
Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability.
The investigators will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing and test different outreach strategies (opt-in vs opt-out) to improve program enrollment.
Conditions
- Covid19
Interventions
- BEHAVIORAL
-
Opt-out Recruitment Email
Behaviorally informed, opt-out framed recruitment email
- BEHAVIORAL
-
Opt-in Recruitment Email
Standard, opt-in framed recruitment email
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mitesh S Patel, MD · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-09
- Primary Completion
- 2020-10-30
- Completion
- 2020-10-30
Countries
- United States
Study Locations
More Related Trials
-
A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia
NCT00002103 ·Status: COMPLETED ·Phase: NA
-
Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program
NCT04363034 ·Status: NO_LONGER_AVAILABLE
-
Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
NCT04502069 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
NCT00002292 ·Status: COMPLETED ·Phase: NA
-
Single-Blind Study of STAT-205 in Mild COVID-19
NCT04708327 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
NCT02255760 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination
NCT01772836 ·Status: COMPLETED ·Phase: PHASE1
-
The Clinical Study of Carrimycin on Treatment Patients With COVID-19
NCT04286503 ·Status: UNKNOWN ·Phase: PHASE4
-
UPMC OPTIMISE-C19 Trial, a COVID-19 Study
NCT04790786 ·Status: TERMINATED ·Phase: PHASE4
-
Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
NCT04295551 ·Status: UNKNOWN ·Phase: NA
-
Oritavancin for Staphylococcus Aureus Infections in Opioid Users
NCT03761953 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
NCT05277350 ·Status: COMPLETED ·Phase: PHASE1
-
A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
NCT00002056 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers
NCT02972255 ·Status: COMPLETED ·Phase: PHASE1
-
Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
NCT02696902 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
NCT00002434 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
NCT01702649 ·Status: COMPLETED ·Phase: PHASE1
-
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
NCT00443885 ·Status: COMPLETED
-
Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV
NCT04245631 ·Status: UNKNOWN
-
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
NCT02452047 ·Status: COMPLETED ·Phase: PHASE3
-
A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.
NCT00002102 ·Status: COMPLETED ·Phase: NA
-
Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
NCT00481689 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine
NCT01995617 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants
NCT01762839 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before
NCT00002291 ·Status: COMPLETED ·Phase: NA